Figure 7From: Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approachesThree dimensional representation of predicted trough FEV 1 improvement at steady state for typical COPD patient as a function of dose and baseline value.Back to article page